DK1383508T3 - Doxycyclin til behandling af acne - Google Patents

Doxycyclin til behandling af acne

Info

Publication number
DK1383508T3
DK1383508T3 DK02731267T DK02731267T DK1383508T3 DK 1383508 T3 DK1383508 T3 DK 1383508T3 DK 02731267 T DK02731267 T DK 02731267T DK 02731267 T DK02731267 T DK 02731267T DK 1383508 T3 DK1383508 T3 DK 1383508T3
Authority
DK
Denmark
Prior art keywords
acne
doxycycline
treatment
human
administering
Prior art date
Application number
DK02731267T
Other languages
English (en)
Inventor
Robert A Ashley
Original Assignee
Collagenex Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23079310&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1383508(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Collagenex Pharm Inc filed Critical Collagenex Pharm Inc
Application granted granted Critical
Publication of DK1383508T3 publication Critical patent/DK1383508T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK02731267T 2001-04-05 2002-04-05 Doxycyclin til behandling af acne DK1383508T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28191601P 2001-04-05 2001-04-05

Publications (1)

Publication Number Publication Date
DK1383508T3 true DK1383508T3 (da) 2006-12-27

Family

ID=23079310

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02731267T DK1383508T3 (da) 2001-04-05 2002-04-05 Doxycyclin til behandling af acne

Country Status (12)

Country Link
EP (4) EP1712236A3 (da)
JP (3) JP2004536046A (da)
KR (1) KR100926326B1 (da)
AT (1) ATE330615T1 (da)
AU (1) AU2002303250B2 (da)
CA (2) CA2719162C (da)
DE (1) DE60212613T2 (da)
DK (1) DK1383508T3 (da)
ES (1) ES2266499T3 (da)
NZ (1) NZ528197A (da)
PT (1) PT1383508E (da)
WO (1) WO2002080932A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005514410A (ja) * 2002-01-08 2005-05-19 パラテック ファーマシューティカルズ インコーポレイテッド ４−デジメチルアミノテトラサイクリン化合物
US8192749B2 (en) 2003-04-16 2012-06-05 Galderma Laboratories Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
AU2003230935B2 (en) * 2002-04-16 2008-08-07 Collagenex Pharmaceuticals, Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
PT1615622E (pt) 2003-04-07 2012-10-17 Supernus Pharmaceuticals Inc Formulações de doxiciclinas de dose única diária
WO2005011707A1 (en) 2003-07-25 2005-02-10 Warner Chilcott Company, Inc. A doxycycline metal complex in a solid dosage form
KR20060108693A (ko) * 2003-11-06 2006-10-18 더 리서치 파운데이션 오브 스테이트 유니버시티 오브 뉴욕 습진의 치료 방법
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US7544373B2 (en) 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7541347B2 (en) 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7704959B2 (en) * 2006-10-03 2010-04-27 Dow Pharmaceutical Sciences Azithromycin for the treatment of nodular acne
KR20130137696A (ko) * 2007-03-23 2013-12-17 몰레큘러 리서치 센터, 인크. 테트라사이클린류를 함유하는 항염증성 조성물 및 이의 치료 용도
WO2008121107A1 (en) * 2007-04-02 2008-10-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
WO2009138516A1 (en) * 2008-05-16 2009-11-19 Galderma Research & Development Therapy regimen for treating acne related diseases
WO2010017310A1 (en) 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
WO2013156853A1 (en) * 2012-04-19 2013-10-24 Galderma S.A. Method of treating acne
RU2557991C1 (ru) * 2014-05-19 2015-07-27 Вячеслав Владимирович Чеботарёв Способ лечения больных вульгарными угрями (акне), страдающих дисплазией соединительной ткани
CO2017001953A1 (es) * 2017-02-27 2018-08-31 Corporacion Univ Lasallista Método de encapsulación de tetraciclinas
WO2019016609A1 (en) * 2017-07-21 2019-01-24 Allergan Pharmaceuticals International Limited TREATMENT OF NON-INFLAMMATORY LESIONS
WO2019135166A1 (en) 2018-01-07 2019-07-11 Dr. Reddy's Laboratories Ltd. Minocycline for treating inflammatory skin conditions
AU2019419387A1 (en) * 2019-01-04 2021-07-22 Dermata Therapeutics, Llc Compositions and methods for the treatment of skin conditions
WO2021215405A1 (ja) * 2020-04-20 2021-10-28 国立大学法人大阪大学 免疫賦活化剤、及び治療又は予防用組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0086228B1 (en) * 1981-08-27 1988-05-11 Soft Sheen Products, Inc. Use of carbamide peroxide for the manufacture of a medicament for treatment of acne vulgaris
US5122519A (en) * 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
ATE194492T1 (de) * 1990-08-16 2000-07-15 Bloom Leonard Topische behandlung von blepharitis
US5674539A (en) * 1994-12-09 1997-10-07 Tomas; Robert E. Method of treating skin and composition
FR2730930B1 (fr) * 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
US5827840A (en) * 1996-08-01 1998-10-27 The Research Foundation Of State University Of New York Promotion of wound healing by chemically-modified tetracyclines
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US5908838A (en) * 1998-02-19 1999-06-01 Medics Pharmaceutical Corporation Method for the treatment of acne
US6432934B1 (en) * 1998-08-06 2002-08-13 Advanced Vision Research Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease
US6015804A (en) * 1998-09-11 2000-01-18 The Research Foundation Of State University Of New York Method of using tetracycline compounds to enhance interleukin-10 production
JP2002525299A (ja) * 1998-09-28 2002-08-13 ザ リサーチ ファウンデーション オブ ステイト ユニヴァーシティ オブ ニューヨーク 新規白内障形成抑制剤
US5998390A (en) * 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
CA2351703C (en) * 1998-11-18 2008-12-30 Collagenex Pharmaceuticals, Inc. Novel 4-dedimethylaminotetracycline derivatives
JP2001072660A (ja) * 1999-09-08 2001-03-21 Welfide Corp ＴＮＦ−α産生抑制剤および／またはＩＬ−１０産生促進剤

Also Published As

Publication number Publication date
CA2440472A1 (en) 2002-10-17
JP2004536046A (ja) 2004-12-02
KR20040007488A (ko) 2004-01-24
EP1716856A3 (en) 2009-02-18
EP1716856A2 (en) 2006-11-02
JP2010053155A (ja) 2010-03-11
EP1712236A2 (en) 2006-10-18
ATE330615T1 (de) 2006-07-15
DE60212613T2 (de) 2007-05-24
CA2719162A1 (en) 2002-10-17
PT1383508E (pt) 2006-11-30
CA2719162C (en) 2014-12-23
JP2011168613A (ja) 2011-09-01
EP1712236A3 (en) 2008-05-28
WO2002080932A1 (en) 2002-10-17
EP2221056A1 (en) 2010-08-25
DE60212613D1 (de) 2006-08-03
EP1383508A4 (en) 2005-07-06
EP1383508B1 (en) 2006-06-21
AU2002303250B2 (en) 2006-05-25
ES2266499T3 (es) 2007-03-01
NZ528197A (en) 2007-04-27
KR100926326B1 (ko) 2009-11-12
EP1383508A1 (en) 2004-01-28
CA2440472C (en) 2011-01-18

Similar Documents

Publication Publication Date Title
DK1383508T3 (da) Doxycyclin til behandling af acne
WO2005046618A3 (en) Methods of treating eczema
DK1039887T3 (da) Anvendelse af aminothiolforbindelser til behandling af neuro- og nefrolidelser og terapeutiske toksiciteter
CY1111536T1 (el) Μεθοδοι και συνθεσεις για την καταστολη της διαφοροποιησης ινοκυτταρων
BR0308813A (pt) Tratamento de tuberculose usando derivados de pleuromutilina
ATE207355T1 (de) Behandlung von hyperproliferativen gefässerkrankungen
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
PT1492561E (pt) Metodo para tratar disturbios da glandula mamaria
WO2003088906A3 (en) Methods of simultaneously treating ocular rosacea and acne rosacea
ES2136252T3 (es) Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa.
ATE191472T1 (de) Neuartige metalloprotease-inhibitoren und diese enthaltende pharmazeutische zusammensetzungen
PL371205A1 (en) Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
WO2004110151A8 (en) Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
ATE393625T1 (de) Behandlung und prävention von übermässiger narbenbildung mit 4-hydroxy tamoxifen
ATE463242T1 (de) Behandlung von inkontinenz
SE9601396D0 (sv) New therapeutic treatment 2
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DE60335093D1 (de) Verwendung von nichtantibakteriellen tetrazyklin-analoga und ihren formulierungen für die behandlung von bakteriellen exotoxinen
WO2006121865A3 (en) Methods of treating recurrent aphthous stomatitis
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы
WO2003103612A3 (en) METHODS OF USING PROSTACYCLINE TO TREAT RESPIRATORY SYNCYTIAL VIRAL INFECTIONS
DK0968174T3 (da) Optisk aktiv 2-aminotetralin, fremgangsmåde til dets fremstilling og farmaceutiske præparater indeholdende selv samme, effektiv til forebyggelse og behandling af septisk chok
ATE526308T1 (de) 13-substituierte methacyclinverbindungen
EA200100768A1 (ru) Применение 3-изоксазолидинонов и гидроксиаминокислот для лечения инфекций